Strides acquires Sandoz branded generics portfolio to expand Sub-Saharan Africa footprint
Strides Pharma has agreed to acquire a portfolio of branded generic products from Sandoz across Sub-Saharan Africa, covering anti-infective, cardiovascular, and dermatology segments. The $12 million deal spans four key markets and includes both full acquisition and continued marketing rights, positioning Strides among the region's top five pharmaceutical companies.